MDGL
#867
Madrigal Pharmaceuticals, Inc. - Common Stock
453.5 5 USD
-0.03%
Market Price
Secteur: Soins de Santé
Base: USD
Devise de Profit: USD
Range quotidien
Range Annuel
Changement quotidien
-2.91%
Changement Mensuel
-16.01%
Evolution sur 6 mois
-14.42%
Changement Annuel
+7.07%
Clôture Précédente
467.1 6
Open
467.1 6
Low
452.0 1
High
467.2 7
Financials
- Market Capitalization 10.48 B
- Employee 915
- Founded 2011
- CEO Paul A. Friedman
- Website www.madrigalpharma.com
- Headquarter Delaware, United States
- FIGI BBG000QS6NV8
- Industry Biotechnologies
Chiffre d'affaires total
Résultat net
Bénéfice par action de base (BPA de base)
Dette totale
Flux de trésorerie disponible
Trésorerie et équivalents de trésorerie
ratio cours/bénéfice
-45.32
ratio cours/chiffre d'affaires
13.63
Related tickers
| # | Nom | Prix | 24h % | 7 jours % | 1M % | 1 an % | Cap Boursière | 7 Derniers Jours | |
|---|---|---|---|---|---|---|---|---|---|
| 822 |  TECH Bio-Techne Corp - Common Stock | 72.50 USD | -0.08% | +0.01% | +0.40% | +23.45% | 11.37 B USD | ||
| 862 |  BMRN BioMarin Pharmaceutical Inc. - Common Stock | 54.36 USD | -1.86% | -4.33% | -18.26% | +4.98% | 10.52 B USD | ||
| 870 |  IBRX ImmunityBio, Inc. - Common Stock | 9.87 USD | -2.47% | -0.80% | +25.10% | +306.17% | 10.46 B USD | ||
| 878 |  PCVX Vaxcyte, Inc. - Common Stock | 68.84 USD | -2.56% | +4.32% | +14.66% | +62.74% | 10.24 B USD |